Nancy Olivieri, born in 1953, is a distinguished physician and biologist based in Toronto, specializing in hematology. With a profound commitment to advancing the treatment of haemoglobinopathies, she has made significant contributions to the field through her research and clinical practice.
Dr. Olivieri is particularly renowned for her extensive and publicized conflict with the Hospital for Sick Children and the pharmaceutical company Apotex regarding the drug deferiprone. This struggle not only highlighted the complexities of medical ethics and patient care but also underscored her dedication to ensuring that patients receive the best possible treatment options.
Throughout her career, Dr. Olivieri has been a passionate advocate for transparency in medical research and the importance of patient safety. Her work continues to inspire both her peers and the next generation of medical professionals.